Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

MiniMed Group, Inc. (MMED)

$16.83 +3.06% NASDAQ: MMED · 15-min delayed
  • NORTHRIDGE, California
  • Public · NASDAQ: MMED
$4.0BMarket cap
$2.3BRevenue · FY2026
-$148.0MNet income
MMEDNASDAQ
2026IPO

About MiniMed Group, Inc.

Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2026
$2.3B
Net income
-$148.0M
Total assets
$4.3B
Market cap
$4.0B
Gross margin
54.2%
Operating margin
-6.1%
Net margin
-10.2%

Source: SEC EDGAR · updated Jun 7, 2026

FY 2026

Financial statements

Income statement

Revenue
$3.1B
Cost of revenue
$1.4B
Gross profit
$1.7B
Operating expenses
$1.9B
Operating income
-$190.0M
Income tax
$128.0M
Net income
-$317.0M
EPS (basic)
$-1.30
EPS (diluted)
$-1.30

Balance sheet

Total assets
$4.6B
Current assets
$1.3B
Total liabilities
$1.0B
Current liabilities
$702.0M
Shareholders’ equity
$3.6B

Cash flow

Operating cash flow
-$197.0M
Investing cash flow
-$233.0M
Financing cash flow
$716.0M
Net cash flow
$286.0M

Statements via Polygon.io (SEC filings)

NASDAQ: MMED
$16.83 +3.06%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$10.80 $18.49

52-week range

Market cap
$4.0B
EPS (diluted)
$-1.3
Shares outstanding
237.4M
Open
Day range
Prev close
Volume
IPO date
Mar 6, 2026

MiniMed Group, Inc. (MMED) Stock Price

  • Reported a net loss of $148.0M in FY2026.
  • Gross margin of 54.2%, net margin -10.2%.
  • Trading 9% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review MiniMed Group, Inc..

Write a review
Newsroom

News about MiniMed Group, Inc.

News & sentiment via Polygon.io

FAQ

MiniMed Group, Inc.: frequently asked questions

Is MiniMed Group, Inc. an American company?

MiniMed Group, Inc. is a US-based company headquartered in Northridge, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is MiniMed Group, Inc. headquartered?

MiniMed Group, Inc. is headquartered in Northridge, California, United States.

Is MiniMed Group, Inc. publicly traded?

Yes — MiniMed Group, Inc. is a publicly traded company. Its stock trades under the ticker symbol MMED on the NASDAQ.

What does MiniMed Group, Inc. do?

MiniMed Group, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →